Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2005 2
2006 3
2007 2
2008 3
2009 2
2011 4
2012 6
2013 2
2014 4
2015 8
2016 12
2017 11
2018 15
2019 10
2020 17
2021 7
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32859699

97 results

Results by year

Filters applied: . Clear all
Page 1
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Rühle A, Grosu AL, Wiedenmann N, Mix M, Stoian R, Niedermann G, Baltas D, Werner M, Weber WA, Kayser G, Nicolay NH. Rühle A, et al. Theranostics. 2020 Jul 23;10(20):9395-9406. doi: 10.7150/thno.48392. eCollection 2020. Theranostics. 2020. PMID: 32802199 Free PMC article. Clinical Trial.
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.
Rühle A, Wiedenmann N, Fennell JT, Mix M, Ruf J, Stoian R, Thomsen AR, Vaupel P, Baltas D, Grosu AL, Nicolay NH. Rühle A, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1650-1660. doi: 10.1007/s00259-021-05602-x. Epub 2021 Nov 13. Eur J Nucl Med Mol Imaging. 2022. PMID: 34773163 Free PMC article. Clinical Trial.
Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
Löck S, Linge A, Seidlitz A, Bandurska-Luque A, Nowak A, Gudziol V, Buchholz F, Aust DE, Baretton GB, Zöphel K, Steinbach J, Kotzerke J, Overgaard J, Zips D, Krause M, Baumann M, Troost EGC. Löck S, et al. Radiother Oncol. 2019 Jun;135:43-50. doi: 10.1016/j.radonc.2019.02.020. Epub 2019 Mar 9. Radiother Oncol. 2019. PMID: 31015169
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
Wiedenmann N, Grosu AL, Büchert M, Rischke HC, Ruf J, Bielak L, Majerus L, Rühle A, Bamberg F, Baltas D, Hennig J, Mix M, Bock M, Nicolay NH. Wiedenmann N, et al. Radiother Oncol. 2020 Sep;150:128-135. doi: 10.1016/j.radonc.2020.06.013. Epub 2020 Jun 13. Radiother Oncol. 2020. PMID: 32544609
97 results